CYKLOKAPRON 100 MG/ML
Google image searchProduct monograph
Active ingredient
tranexamic acid, 100 MG/ML
DIN: 02064413
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 15-FEB-2006
ATC:
- B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
- B02A — ANTIFIBRINOLYTICS (ATC, ATC/DDD)
- B02AA — Amino acids (ATC, ATC/DDD)
- B02AA02 — TRANEXAMIC ACID (ATC/DDD)
Reference brand drug: Cyklokapron
Pharmaceutical standard: BP
